Cefixime
| Clinical data | |
|---|---|
| Trade names | Suprax, others[1] |
| AHFS/Drugs.com | Monograph |
| MedlinePlus | a690007 |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Bioavailability | 30 to 50%[5] |
| Protein binding | Approximately 60% |
| Elimination half-life | Variable Average 3 to 4 hours |
| Excretion | Kidney and biliary |
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.119.331 |
| Chemical and physical data | |
| Formula | C16H15N5O7S2 |
| Molar mass | 453.44 g·mol−1 |
| 3D model (JSmol) | |
SMILES
| |
InChI
| |
| (what is this?) (verify) | |
Cefixime, sold under the brand name Suprax among others, is an antibiotic medication used to treat a number of bacterial infections.[5] These infections include otitis media, strep throat, pneumonia, urinary tract infections, gonorrhea, and Lyme disease.[5] For gonorrhea typically only one dose is required.[6] In the United States it is a second-line treatment to ceftriaxone for gonorrhea.[5] It is taken by mouth.[5]
Common side effects include diarrhea, abdominal pain, and nausea.[5] Serious side effects may include allergic reactions and Clostridioides difficile diarrhea.[5] It is not recommended in people with a history of a severe penicillin allergy.[6] It appears to be relatively safe during pregnancy.[7] It is in the third-generation cephalosporin class of medications.[5] It works by disrupting the bacteria's cell wall resulting in its death.[5]
Cefixime was patented in 1979 and approved for medical use in the United States in 1989.[5][8] It is on the World Health Organization's List of Essential Medicines.[9] It is available as a generic medication in the United States.[10]
- ^ Cite error: The named reference
genericnameswas invoked but never defined (see the help page). - ^ "Antibiotics". Health Canada. 8 May 2018. Retrieved 13 April 2024.
- ^ "Regulatory Decision Summary for Auro-Cefixime". Drug and Health Products Portal. 9 November 2016. Retrieved 13 April 2024.
- ^ "Suprax 200 mg Tablets - Summary of Product Characteristics (SmPC)". (emc). 20 August 2019. Archived from the original on 22 September 2020. Retrieved 23 April 2020.
- ^ a b c d e f g h i j "Cefixime". The American Society of Health—System Pharmacists. Archived from the original on 27 November 2016. Retrieved 8 December 2016.
- ^ a b World Health Organization (2009). Stuart MC, Kouimtzi M, Hill SR (eds.). WHO Model Formulary 2008. World Health Organization. p. 107. hdl:10665/44053. ISBN 9789241547659.
- ^ "Cefixime (Suprax) Use During Pregnancy". Drugs.com. 29 March 2019. Retrieved 24 December 2019.
- ^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 495. ISBN 9783527607495.
- ^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
- ^ "Generic Suprax Availability". Drugs.com. Retrieved 23 April 2020.